Literature DB >> 19091520

Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea.

Kyungwon Lee1, Mi-Na Kim, Tae Yeal Choi, Soung-Eun Cho, Seungok Lee, Dong Hee Whang, Dongeun Yong, Yunsop Chong, Neil Woodford, David M Livermore.   

Abstract

Carbapenem-resistant Acinetobacter spp. are being increasingly reported worldwide, including in South Korea, where we examined 144 representative isolates collected in a nationwide hospital survey in 2005. Metallo-beta-lactamases were detected in only 19.4% of isolates, none of which were Acinetobacter baumannii, whereas 74.3% of isolates (mostly A. baumannii) expressed bla(OXA) carbapenemase genes. Among the latter, 47 had bla(OXA-23)-like genes and 56 had upregulated bla(OXA-51)-like variants, including bla(OXA-66), (-83), (-109) and (-115); bla(OXA-115) was a novel variant, detected in two isolates. bla(OXA-72) (bla(OXA-40)-like) was detected in only a single Acinetobacter baylyi isolate, whilst three Acinetobacter calcoaceticus isolates had both bla(VIM-2)-like and bla(OXA-58) genes. Pulsed-field gel electrophoresis (PFGE) suggested the spread of A. baumannii clones with OXA carbapenemases within and between hospitals. In conclusion, the recent increase in imipenem-resistant Acinetobacter spp. from South Korea is mostly due to OXA-type carbapenemases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091520     DOI: 10.1016/j.ijantimicag.2008.10.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  24 in total

1.  First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.

Authors:  Maria Camila Montealegre; Juan José Maya; Adriana Correa; Paula Espinal; Maria F Mojica; Sory J Ruiz; Fernando Rosso; Jordi Vila; John P Quinn; Maria Virginia Villegas
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

2.  Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania.

Authors:  Guo-Bao Tian; Jennifer M Adams-Haduch; Tatiana Bogdanovich; Anthony W Pasculle; John P Quinn; Hong-Ning Wang; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

3.  High prevalence of carbapenem-resistant Acinetobacter baumannii carrying the blaOXA-143 gene in Brazilian hospitals.

Authors:  Charline S Antonio; Patrícia R Neves; Micheli Medeiros; Elsa M Mamizuka; Maria R Elmor de Araújo; Nilton Lincopan
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

4.  Dissemination of 16S rRNA methylase ArmA-producing acinetobacter baumannii and emergence of OXA-72 carbapenemase coproducers in Japan.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

5.  Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.

Authors:  Kyungwon Lee; Mi Ae Lee; Chae Hoon Lee; Jongwook Lee; Kyoung Ho Roh; Sunjoo Kim; Jin Ju Kim; Eunmi Koh; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

6.  Evaluation of double-disk potentiation and disk potentiation tests using dipicolinic acid for detection of metallo-β-lactamase-producing pseudomonas spp. and Acinetobacter spp.

Authors:  Dongeun Yong; Yangsoon Lee; Seok Hoon Jeong; Kyungwon Lee; Yunsop Chong
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

7.  Detection of SPM-1-producing Pseudomonas aeruginosa and class D β-lactamase-producing Acinetobacter baumannii isolates by use of liquid chromatography-mass spectrometry and matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Cecilia G Carvalhaes; Rodrigo Cayô; Diego M Assis; Evelin R Martins; Luiz Juliano; Maria A Juliano; Ana C Gales
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

Review 8.  OXA β-lactamases.

Authors:  Benjamin A Evans; Sebastian G B Amyes
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 9.  Diversity, epidemiology, and genetics of class D beta-lactamases.

Authors:  Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

Review 10.  β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.

Authors:  Hosam M Zowawi; Hanan H Balkhy; Timothy R Walsh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.